Harmony Biosciences Holdings, Inc. (HRMY) stock forecast — our track record

Lyra published 6 HRMY stock forecasts from July 1, 2025 through the last closed window ending January 21, 2026. Each stock forecast was published before the outcome was known, and every prediction was later closed and scored. All 6 calls used the short term (0 to 3 months) horizon. There were no medium term (3 to 12 months) or long term (12 to 24 months) calls in this record, so the result was entirely based on short term forecasts.

Overall, 3 HRMY predictions reached their targets. None of them missed. The other 3 were partial outcomes. The average success score was 75%. The short term average score was also 75%, matching the only horizon Lyra used for this stock. The average peak gain was 34.4%. That made the track record positive, but not perfect. Half of the calls reached their target, while the rest rose but did not reach the full forecasted move.

The best call was published on October 12, 2025. Lyra predicted 40% growth, and the stock rose as much as 54%. That target was reached in 53 days, with a 100% score. The weakest call was published on July 7, 2025. Lyra predicted 30% growth, and the stock rose as much as 17.8%. It did not reach the target and scored 50%. The record was clean on direction, with no misses, but only 3 calls reached the full target.